Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 10, 2018
Effect of non-compliant balloon postdilatation on magnesium-based bioresorbable vascular scaffoldsFlorian Blachutzik, Stephan Achenbach, Monique Tröbs, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 3, 2017
Characteristics and outcome of patients with complex coronary lesions treated with bioresorbable scaffolds: three-year follow-up in a cohort of consecutive patientsRemzi Anadol, Liv Lorenz, Melissa Weissner, et al.BMC Cardiovascular Disorders|May 11, 2018
Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffoldsRemzi Anadol, Katharina Schnitzler, Liv Lorenz, et al.Journal of Clinical Medicine|January 18, 2019
Procedural Predictors for Bioresorbable Vascular Scaffold Thrombosis: Analysis of the Individual Components of the "PSP" TechniqueZisis Dimitriadis, Alberto Polimeni, Remzi Anadol, et al.European Heart Journal|November 7, 2015
Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanismsTommaso Gori, Thomas Jansen, Melissa Weissner, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 12, 2018
Major coronary evaginations following implantation of bioresorbable vascular scaffolds - Clinical and OCT characteristicsFlorian Blachutzik, Stephan Achenbach, Mohamed Marwan, et al.JACC. Cardiovascular Interventions|September 23, 2017
Incidence, Clinical Presentation, and Predictors of Clinical Restenosis in Coronary Bioresorbable ScaffoldsAlberto Polimeni, Melissa Weissner, Katharina Schochlow, et al.JACC. Cardiovascular Interventions|December 9, 2017
Characteristics, Predictors, and Mechanisms of Thrombosis in Coronary Bioresorbable Scaffolds: Differences Between Early and Late EventsTommaso Gori, Melissa Weissner, Svenja Gönner, et al.Clinical Hemorheology and Microcirculation|April 10, 2018
Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1Remzi Anadol, Zisis Dimitriadis, Alberto Polimeni, et al.JACC. Cardiovascular Interventions|May 23, 2015
Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary SyndromesTommaso Gori, Eberhard Schulz, Ulrich Hink, et al.Pageof 2